Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment

Rozalina McCoy, Steven Smith

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'Review: In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment'. Together they form a unique fingerprint.